Literature DB >> 15846565

Benign ovarian masses.

Claire L Templeman1, Mary E Fallat.   

Abstract

Primary tumors of the ovary are uncommon in children and the majority of these masses are not malignant. As newer diagnostic imaging techniques have increased the detection of all ovarian masses, the frequency of ovarian cancer has actually decreased. Clinical symptoms are generally not helpful in distinguishing benign from malignant masses, but radiographic criteria have been developed. Surgical treatment is aimed at ovarian preservation if the lesion proves benign.

Entities:  

Mesh:

Year:  2005        PMID: 15846565     DOI: 10.1053/j.sempedsurg.2005.01.004

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  5 in total

Review 1.  Assessing gonadal function after childhood ovarian surgery.

Authors:  Amy Zhai; Jason Axt; Emma C Hamilton; Elizabeth Koehler; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

2.  Ovarian lesions and tumors in infants and older children.

Authors:  Henning C Fiegel; Stefan Gfroerer; Till-Martin Theilen; Florian Friedmacher; Udo Rolle
Journal:  Innov Surg Sci       Date:  2021-08-11

3.  GATA-4 and FOG-2 expression in pediatric ovarian sex cord-stromal tumors replicates embryonal gonadal phenotype: results from the TREP project.

Authors:  Calogero Virgone; Giovanni Cecchetto; Andrea Ferrari; Gianni Bisogno; Vittoria Donofrio; Renata Boldrini; Paola Collini; Patrizia Dall'Igna; Rita Alaggio
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 4.  Gonadal germ cell tumors in children and adolescents.

Authors:  Giovanni Cecchetto
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

5.  The Value of MRI Findings Combined With Texture Analysis in the Differential Diagnosis of Primary Ovarian Granulosa Cell Tumors and Ovarian Thecoma-Fibrothecoma.

Authors:  Nai-Yu Li; Bin Shi; Yu-Lan Chen; Pei-Pei Wang; Chuan-Bin Wang; Yao Chen; Ya-Qiong Ge; Jiang-Ning Dong; Chao Wei
Journal:  Front Oncol       Date:  2021-10-27       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.